Andrea B. Posted October 14, 2003 Share Posted October 14, 2003 One of my mom's oncology nurses just returned from a cancer seminar (lung cancer was included). The nurse mentioned that there is a new study out that showed patients who have received the full dosage of their chemo versus patients who have received reduced dosages (my mom is currently only receiving 85% potentcy of Gemzar/Taxotere). The findings showed that the 5 year survival rate for patients in both categories were pretty equal, but past the 5 year mark those that received their full dosages had longer life spans. This is all I know right now, but I thought it was interesting. I plan to ask more when I see her nurse. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.